Physician profile
Walker C May
NPI 1003083205
$1,715.80
in general payments reported to CMS, 2019-2025
21 companies · $92.05 in 2025
The $92.05 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $222 · 2021: $474 · 2022: $242 · 2023: $216 · 2024: $136 · 2025: $92.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.35 |
| Education | $139.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $696.29 | 2019-2022 | |
| Lilly USA, LLC | $144.47 | 2021-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $119.54 | 2019-2023 | Trelegy Ellipta, Shingrix, Arexvy |
| Astellas Pharma US INC | $110.61 | 2023 | Veozah |
| Pfizer INC. | $100.94 | 2019-2025 | |
| Melinta Therapeutics, LLC | $94.10 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.83 | 2019-2024 | |
| Novo Nordisk INC | $54.38 | 2020-2021 | |
| Daiichi Sankyo INC. | $46.74 | 2021-2022 | |
| Mylan Specialty L.P. | $46.15 | 2021-2024 | Yupelri |
| Astrazeneca Pharmaceuticals Lp | $42.71 | 2020-2024 | Breztri |
| Exact Sciences Corporation | $29.67 | 2023-2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.34 | 2022 | |
| Hologic Sales and Service, LLC | $21.63 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.68 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $16.44 | 2025 | Omnipod |
| Takeda Pharmaceuticals U.S.A., INC. | $16.42 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.79 | 2021 | |
| Organogenesis INC. | $13.53 | 2023 | Puraply |
| Xeris Pharmaceuticals, INC. | $12.93 | 2022 | |
| Inogen, INC. | $9.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walker May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.